Linked Life Data

19394651

Source:http://linkedlifedata.com/resource/pubmed/id/19394651

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2009-12-16
pubmed:abstractText
The hypervascular nature of hepatocellular carcinoma (HCC) has led a number of investigators to explore the potential of anti-angiogenic therapy for this cancer. We aimed to investigate the efficacy of anti-angiogenetic therapy for the prevention and treatment of HCC.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1095-8673
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
158
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
69-76
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Anti-angiogenic therapy on hepatocellular carcinoma development and progression.
pubmed:affiliation
Department of Surgery, Jikei University School of Medicine, Minato-ku, Tokyo, Japan. yujiyunayuta@jikei.ac.jp
pubmed:publicationType
Journal Article